By BRAASCH BIOTECH LLC Braasch Biotech LLC, an emerging biopharmaceutical company pioneering a new field of anti-somatostatin vaccines, today announced a Notice of Allowance was received from the Japan Patent Office on July 15, 2025, for Braasch's patent entitled...
|
By DPI Research The United States vaccine market was valued at around USD 29.5 billion in 2024 and is projected to reach around USD 60 billion by 2033, exhibiting a CAGR of 8 % during the forecast period.
|
By DPI Research The global influenza vaccine market size was valued at USD 7.8 billion in 2023 and is likely to reach USD 13.7 billion in 2032, expanding at a CAGR of 7.2% during the forecast period.
|
By DPI Research The global influenza vaccines market size was valued at USD 7.8 Billion in 2023 and is likely to reach USD 13.7 Billion in 2032, expanding at a CAGR 7.2% during the forecast period.
|
By DPI Research [DPI Research Latest Report] The global influenza vaccines market size was valued at USD 7.8 Billion in 2023 and is likely to reach USD 13.7 Billion in 2032, expanding at a CAGR 7.2% during the forecast period.
|
By DPI Research The report offers the most up-to-date industry data on the actual market situation and future outlook in the global influenza vaccines market.
|
